Lipopolysaccharide (LPS) is a known causative agent of sepsis. In previous studies, we have shown that it reduces L-leucine mediated transport across the rabbit jejunum by about 30%. In this study, the mechanism(s) of LPS inhibition on amino acid transport were analysed in detail. LPS did not inhibit Lleucine transport across brush border membrane vesicles, suggesting the need for an intracellular step. The inhibitory effect of LPS was not altered by the addition of protein kinase A (PKA) inhibitor (IP 20 , 10 -7 M) or an analog of cAMP (DB-cAMP, 3 ´10 -4 M), indicating that the PKA signal transduction pathway was not involved in the LPS effect. However, the inhibitory effect of LPS was suppressed by trifluoroperazine (10 -7 M), a Ca 2+ /calmodulin inhibitor and staurosporine (10 -7 M), an protein kinase C (PKC) inhibitor. Likewise, LPS inhibition disappeared in media without calcium. These results suggest that LPS could inhibit the intestinal uptake of L-leucine across the small intestine in vitro by intracellular processes related to calcium, involving PKC and calmodulin protein.
INTRODUCTION
Infectious agents can cause intestinal malfunctions which alter gastrointestinal motility and absorption. During sepsis, alterations in the barrier function of the gastrointestinal (GI) tract are brought about by endotoxin, a complex of lipopolysaccharides associated with proteins. 1 Lipopolysaccharide (LPS) is a lipocarbohydrate component of endotoxin and a major cell wall component of most Gramnegative bacteria. 2 Normally, the intestinal tract contains large populations of Gram-negative bacteria which are the source of endotoxins in many clinical problems. 3 Studies in several animal models have demonstrated that luminal bacteria play an important role in the pathogenesis of chronic intestinal inflammation. 4 The primary function of the GI tract is the absorption of water, electrolytes and nutrients. Endotoxins modify the intestinal absorption of water and electrolytes [5] [6] [7] [8] and can have both a direct and indirect effect on sugar and amino acid transport.
O'Loughin et al. 9 demonstrated that intragastric Yersinia enterocolitica infection in vivo decreases glucose absorption across the rabbit jejunum. In kinetic studies using rats with an intraperitoneal infection of Escherichia coli, LPS decreases sodium-dependent jejunal glutamine uptake across brush border and reduces maximal transport velocity. Sodium-dependent glutamine, alanine, leucine and glucose transport are also lower in septic patients. 10 Similar results are obtained for the absorption of glucose in swine intestine after intravenous administration of E. coli LPS. 11 In rabbit ileum, intragastric infection with Eimeria magna inhibits glucose transport by decreasing the number of cotransporters and inhibiting Na + /K + -ATPase. 12 Intraperitoneal administration of E. coli LPS significantly impairs the intestinal absorption of several amino acids. The magnitude of this effect depends on the amino acid in question, suggesting that not all transport systems are affected equally. 13 Sundaram et al. 14 reported that alanine uptake is decreased due to a reduced transport affinity and Na + /K + -ATPase activity in chronically inflamed rabbit ileum after coccidial infection.
Previous studies in our laboratory have demonstrated that adding E. coli LPS directly to rabbit jejunum partially reduces L-leucine mediated transport by inhibiting Na + /K + -ATPase and reducing transport affinity. 15 In this paper, we set out to determine the mechanism(s) involved in this inhibition. 
MATERIALS AND METHODS

Materials
Animals and preparation of intestinal tissue
Handling, equipment used, and sacrifice of animals was in accordance with the European Council legislation 86/609/EEC concerning experimental animal protection. Male New Zealand rabbits, weighing 1.8-2.0 kg, were maintained at a constant room temperature (24°C) with free access to water and standard rabbit fodder. After killing with a blow to the head, the proximal jejunum was removed and rinsed free of intestinal contents with ice-cold Ringer's solution which contained: 140 mM NaCl, 10 mM KHCO 3 , 0.4 mM KH 2 PO 4 , 2.4 mM K 2 HPO 4 , 1.2 mM CaCl 2 and 1.2 MgCl 2 , pH 7.4. In experiments where Ca 2+ -free conditions were required, CaCl 2 was replaced isotonically by choline chloride.
Cell water determinations
Rings of everted jejunum were incubated in Ringer's solution at 37°C containing 0.02 mCi/ml [ 14 C]-PEG 4000 for 15 min and continuously bubbled with 95% O 2 /5% CO 2 . After incubation, the pieces of tissue were gently blotted on moist filter paper, weighed and incubated overnight in 0.5 ml of 0.1 M HNO 3 at 4°C to extract PEG from the tissue. Aliquots of 200 ml from the extracts and from the bathing solutions were then counted in 2 ml of scintillation liquid. Following extraction from HNO 3 , the tissues were dried at 80°C for 12 h and then re-weighed. Total tissue water was calculated as the difference between the wet and dry weight. The extracellular water was obtained from the PEG tissue content. The intracellular water was calculated by the difference between total and extracellular tissue water. The tissue volumes were not modified by the different experimental conditions (data not shown).
Amino acid uptake measurements
Rings of everted jejunum weighing about 100 mg were continuously bubbled with 95% O 2 /5% CO 2 . The Ringer's solution was supplemented with 0.01 mCi/ml of L-[U-14 C]-leucine plus 0.5 mM unlabeled substrate. The tissues were pre-incubated for 12 min in media with or without LPS or other modifiers and incubated for 3 min to measure the initial uptake of L-leucine. At the end of the experiment, the rings were washed with two or three gentle shakes in ice-cold Ringer's solution and blotted carefully on both sides to remove excess moisture. The tissue was weighed wet and the accumulated substrate was extracted by shaking for 15 h in 0.5 ml 0.1 M HNO 3 at 4°C. Samples (200 ml) were taken from the bathing solutions and from the extracts of the tissues for radioactivity counting. The measurements were expressed as mmoles L-leucine per ml cell water, after correcting for the intracellular water.
Brush border membrane vesicles (BBMVs): preparation and transport of L-leucine assessment
BBMVs were prepared using the Mg 2+ -EGTA precipitation method 16 with minor modifications. 17 The final preparation contained 300 mM mannitol and 10 mM HEPES-Tris pH 7.4 buffer. The BBMVs were immediately used for the transport studies, without freezing. Protein was measured using the Bradford method 18 with a bovine serum albumin standard. The purity of the membrane preparations was determined by measuring enzymatic sucrase activity using the Dahlqvist method. 19 Na + /K + -ATPase activity (marker of basolateral membrane) was also determined.
Substrate uptake was measured as a time function (5, 10, 40, 60 s and 120 min to reach equilibrium). Timecourse incubations at room temperature (~25°C) were initiated by adding 5 ml (200 mg) of BBMVs to 45 ml of incubation medium. The incubation medium contained HEPES-Tris (10 mM), 0.01 mCi/ml L-[U-14 C]-leucine plus 0.1 mM unlabeled substrate and 100 mM NaCl to give a 100/0 mM (out/in) initial metal-ion gradient, and D-mannitol was added in order to reach 300 mosmol/l. The results are expressed as absolute uptake of L-leucine in pmoles/mg vesicle protein.
Statistical analysis
All results are expressed as mean ± SE. Means were compared using a one-way analysis of variance (ANOVA). The Fisher's protected least significant difference test (PLSD) was used as a multiple-comparison method to compare data between groups and considered statistically significant when P < 0.05. 20
RESULTS
Effect of LPS on L-leucine uptake in brush border membrane vesicles (BBMVs)
Previous studies in our laboratory have shown that Lleucine mediated transport is inhibited by about 30% when the intestinal tissue is directly exposed to LPS (3´ 10 -5 mg/ml) for 15 min. 15 We studied the effect of LPS on enterocyte BBMVs to determine whether the endotoxin had a direct effect on the jejunum or whether it required intracellular mechanisms to inhibit amino acid transport.
We established four experimental groups. In the first group (control), L-leucine uptake was measured in vesicles from control intestinal tissue without LPS. In the second group (LPS), L-leucine uptake was measured in vesicles from control intestinal tissue with 3´10 -5 mg/ml LPS. In the third group (ves. Pre.), L-leucine uptake was studied in BBMVs which were pre-incubated with 3´10 -5 mg/ml LPS for 15 min before uptake. In the last group (Tissue Pre.), L-leucine uptake was measured in BBMVs from intestinal tissue pre-incubated with 3´10 -5 mg/ml LPS for 15 min. The incubation times for L-leucine transport were 5, 10, 40 and 60 s and 120 min to reach equilibrium.
In Figure 1 , the intravesicular concentration of L-leucine is seen to rise transiently above (overshoot) its equilibrium value (15 s) and then fall back to equilibrium as the sodium gradient dissipates (120 min). This demonstrates a functional secondary active transport mechanism to Lleucine in these vesicles.
LPS did not significantly affect the 0.1 mM L-leucine uptake across the brush border membrane vesicles under the different conditions (Fig. 1 ). This suggests that the LPS effect on L-leucine intestinal absorption required intact cells. Indeed, L-leucine uptake in enterocyte BBMVs remained the same as the control for LPS direct addition (LPS group), LPS pretreated vesicles (ves. Pre. group), and LPS pretreated tissue (Tissue Pre. group).
Is cAMP implicated in the LPS action on L-leucine uptake?
Since LPS had no effect on BBMV L-leucine uptake, we considered the possible implication of second messengers. First, cAMP was analysed since it is a second messenger in many physiological processes. We added a protein kinase A (PKA) inhibitor ( kinase. Neither one altered the control conditions or the LPS effect on 0.5 mM L-leucine absorption (Fig. 2) .
Implication of protein kinase C in LPS action on Lleucine uptake
A great deal of evidence suggests that protein kinase C (PKC) plays an important role in the modulation of cellular functions, including membrane transport processes. [21] [22] [23] We added 10 -7 M staurosporine, a PKC inhibitor, to measure its effect on 0.5 mM L-leucine uptake (3 min of incubation). It inhibited the effect of LPS.
The role of PKC was corroborated with 10 -7 M PMA, a PKC activator. PMA inhibited the L-leucine uptake in the presence or absence of the endotoxin at the same level of LPS. This effect disappeared when the medium contained PMA and staurosporine 10 -7 M (Fig. 3) , suggesting that LPS may act through PKC stimulation.
Role of intra-and extracellular calcium in LPS action on L-leucine uptake
PKC second messenger pathway(s) are strongly linked to calcium. We studied the effect of intra-and extracellular Ca 2+ in LPS action on L-leucine intestinal uptake. A series of experiments were carried out in media with or without Ca 2+ and with or without TMB-8 (an inhibitor of intracellular Ca 2+ release) and trifluoroperazine (a calmodulin antagonist). LPS had no effect on 0.5 mM Lleucine uptake in the absence of extracellular calcium. Thus, calcium was required for L-leucine uptake and for the LPS effect. However, when TMB-8 was added to medium, the LPS effect remained in media with calcium ( Fig. 4 ), suggesting that the LPS effect is dependent on extracellular calcium levels, but not intracellular calcium release. Finally, when trifluoroperazine was added, the L-leucine intestinal absorption was not inhibited by LPS, indicating that calcium and calmodulin play a role in the inhibition of L-leucine uptake induced by LPS.
DISCUSSION
The absorption of sugar and amino acids across the small intestine can be inhibited by infectious agents. [9] [10] [11] [12] [13] [14] 24, 25 Previous studies in our laboratory have shown that the direct addition of LPS to intestinal tissue inhibits Na + - dependent L-leucine intestinal absorption. This effect was increased by pre-incubating the intestine with the endotoxin, indicating that some time is needed before LPS can inhibit amino acid uptake significantly. 15 Therefore, the LPS effect on intestinal amino acid absorption is not instantaneous and perhaps not only dependent on the direct fixation to the endotoxin on the epithelium. In this study, we found that the inhibitory effect of LPS on L-leucine intestinal absorption requires intact cells. LPS did not significantly affect amino acid uptake across BBMVs even when they were prepared from LPS preincubated tissue, pre-incubated in LPS or when LPS was added directly to the incubation medium ( Fig. 1) . Thus, it appears that intracellular processes could mediate the LPS effect. However, other studies have shown that LPS decreases uptake of glutamine, alanine, leucine and glucose by brush border vesicles. 10 This apparent contradiction could be explained by the different ways the endotoxin was administered. We applied LPS directly to the incubation medium, i.e. LPS acted directly on the enterocytes of the intestinal epithelium. Salloum et al. 10 used a systemic administration. Moreover, our group have found that intravenous administration of LPS decreases L-leucine uptake in brush border vesicles, 26 suggesting that endotoxin alters intestinal sodium-dependent amino acid transport as a function of the administration route. These results also suggest that, during sepsis, nutrients could be absorbed differently depending on whether the infection occurs directly in the GI tract or is a result of a systemic infection.
The regulation of cellular function by molecules which bind to cell surface receptors (such as LPS) is initiated by signal transduction mechanisms that generate intracellular signals, or second messengers. These second messengers interact with specific target molecules to initiate a cascade of biochemical events which change cellular functions. A variety of intracellular second messengers are generated in response to extracellular stimuli, including divalent ions, phospholipid metabolites and cyclic nucleotides.
cAMP is one of the main intracellular mediators of fluid and electrolyte secretion in the small intestine. 27 The expression and function of SGLT1 (sodium-glucose co-transporter) and GLUT5 fructose transporter are upregulated by PKA and cAMP. 28, 29 We showed that cAMP did not modify the inhibitory effect of LPS on L-leucine uptake since IP 20 (a PKA inhibitor) and DB-cAMP (a non-metabolizable analogue of cAMP) had no effect (Fig. 2) .
PKC is another second messenger that plays an important role in the cell signal transduction of many physiological processes such as membrane functions. 30 PKC is important in the sensitization of endothelial cells to bacterial endotoxin challenge. [31] [32] [33] PKC has also been described in relation to transport of electrolytes in rat colon and ileum, 34, 35 and sodium-glucose, L-arginine and L-alanine transport in different cell lines. 28, [36] [37] [38] [39] In order to elucidate whether PKC was involved in LPS inhibition, staurosporine and PMA were used as a PKC inhibitor and activator, respectively. LPS did not affect L-leucine transport in the presence of staurosporine ( Fig. 3 ). This suggested that LPS could induce L-leucine inhibition by PKC activation. This hypothesis was corroborated when the LPS effect was reproduced by addition of PMA to the incubation medium ( Fig. 3) .
Our findings are in agreement with several reports where the PKC isotype eta is the intracellular mediator of endotoxin effects. PKC is a major second messenger component in the signaling pathway regulating LPS induced iNOS expression. [40] [41] [42] [43] [44] Calcium also acts as an intracellular second messenger. 45 Cells contain intracellular calcium-binding proteins, among which calmodulin is the most important. 46, 47 Calcium plays an important role in electrolyte intestinal transport regulation via Ca 2+ /calmodulin (CaM) and/or PKC systems. 35 Consequently, calcium and PKC are important in Campylobacter jejuni-induced changes in Na + and Cltransport in rat ileum in vitro. 32 CaM and PKC also control K + -transport in rat distal colon. 34 Until now, calcium has not been reported to modulate the effects of LPS. Nonetheless, we found that, without calcium, L-leucine uptake was not inhibited by LPS. Thus, extracellular calcium plays an important role in intestinal L-leucine uptake and is necessary for LPS action. This is similar to the finding that D-galactose uptake in rabbit jejunum is modified when calcium channels are blocked. 48 However, TMB-8, an inhibitor of intracellular Ca 2+ release, does not modify the endotoxin effect. This could be because intracellular calcium liberated via inositolphosphates is not implicated or is not essential for LPS action. The fact that trifluoroperazine (an inhibitor of CaM) eliminated the LPS effect on L-leucine intestinal uptake suggests that LPS involves calcium, via its interaction with calmodulin, as an intracellular messenger in the inhibition of L-leucine intestinal transport.
A possible mechanism to explain the effect of LPS on L-leucine intestinal absorption could involve Toll-like receptors (TLR). TLR-2 is present in intestinal epithelial cells 49 and may be activated when intestinal bacterial cell wall concentrations are pathologically high. LPS activation of TLR-2 can induce the transcription factor NF-kB and several pro-inflammatory cytokines. 50,51 NF-kB and/or cytokines could induce a second messenger molecule (Ca 2+ /calmodulin; PKC) to start an intracellular signaling cascade. Another possibility could be that LPS uses TLR to induce an intracellular calcium influx and activate PKC, which then behaves as a second messenger to mediate inflammatory cytokine secretion. Moreover, PKC can cross-talk with Ca 2+ /calmodulin-dependent protein kinase, 52 so the LPS activation of PKC and Ca 2+ influx intracellular pathways could be modulated as a function of LPS or bacterial concentration level. In addition, all these intracellular second messengers are well-known regulators and/or modulators of intestinal ion transporters, 32, 34, 35 and sugars and amino acids. [36] [37] [38] [39] 48 Consequently, PKC and Ca 2+ /calmodulin could be involved in the intracellular mechanisms that mediate LPS induced L-leucine uptake reduction across the rabbit jejunum.
